ArticleThe Canadian journal of urology2026
Autologous blood coagulum for fragment removal after ureteroscopic laser lithotripsy.
Article in The Canadian journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUreteroscopy is the recommended surgical treatment for renal stones less than two centimeters in diameter but often leaves residual fragments, increasing the risk of stone recurrence. Autologous blood coagulum is a potential adjunct to ureteroscopy for aiding fragment retrieval. This study evaluates the efficacy and efficiency of autologous blood coagulum assisted ureteroscopy compared to ureteroscopy and basketing for achieving absolute stone-free Grade A status.
methodsFollowing Institutional Review Board approval, a retrospective review of our comprehensive UC Irvine Minimally Invasive Surgery Ureteroscopy database consisting of 962 patients undergoing ureteroscopy between 2018 to 2025 identified 15 renal units treated with ureteroscopy plus autologous blood coagulum and 47 matched controls treated with standard ureteroscopy and basketing alone. Primary outcomes included absolute stone-free status and stone-free rate, with operative time as a secondary outcome. Multivariate logistic regression was used to determine factors most closely associated with stone-free status.
resultsAutologous blood coagulum increased the proportion of patients achieving absolute stone-free Grade A status (60% vs. 19%; p = 0.007) and was associated with a greater odds of achieving Grade A status compared to standard ureteroscopy (OR = 4.6; 95% CI = 1.04-20.1; p = 0.044). In patients who received autologous blood coagulum, thulium laser use was associated with a significantly greater odds of achieving Grade A status (OR 6.7; 95% CI: 1.1-39; p = 0.047). There was no significant difference in the relative stone free rates for fragments ≤4 mm (Grades A+B+C) between groups (73% vs. 60%; p = 0.38). Mean operative time for autologous blood coagulum vs. the control group was comparable (141.1 vs. 135.1 min; p = 0.76).
conclusionsAutologous blood coagulum is an effective adjunctive technique to standard ureteroscopy that enhances stone-free outcomes without prolonging operative duration or requiring any additional equipment or expense.
Indexed as
Identifiers
42682054What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.